Clearstate Insights Asia-Pacific infectious disease diagnostics market trends In Asia-Pacific (APAC), many countries continue to build up in vitro diagnostics (IVD) testing capacity to strengthen the country’s response to infectious diseases. Clearstate expects infectious disease testing to grow. In-vitro diagnostics | Infectious Diseases Testing Monitor | Uncategorised | Asia | Infectious Diseases Testing Monitor | IVD Gateway
Clearstate Insights Elective surgery volume expected to make full recovery in 2023-24 Cardiovascular surgery | Orthopaedic & Spine Surgery | Surgical device and IVD | Asia | Cardiovascular Surgery | Orthopaedic & Spine Surgery | Surgical Gateway | Surgical Procedure Volume Segmentation
Clearstate Insights Medtech 2022/2023: seeking sustainable growth In-vitro diagnostics | Surgical device and IVD | Global | IVD Gateway | Surgical Gateway
Clearstate Insights Highlights from the 2022 APAC surgical device market briefing General surgery | Surgical device and IVD | Asia | General Surgery | Surgical Gateway
Gateway Solutions: Data-driven intelligence for the healthcare industryWe identify realistic opportunities and enable growth strategies through current, credible, granular data for the IVD and Surgical sectors. Learn more